Skip to content 
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. more
| Time Frame | MCK | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 2.58% | 0.34% | -0.9% |
| 1-Month Return | -8.99% | 0.83% | 5.3% |
| 3-Month Return | -19.25% | -7.2% | 8.59% |
| 6-Month Return | -11.49% | -4.84% | 12.48% |
| 1-Year Return | 6.65% | 11.82% | 27.21% |
| 3-Year Return | 93.35% | 11.94% | 77.13% |
| 5-Year Return | 278.18% | 18.31% | 78.67% |
| 10-Year Return | 329.05% | 111.97% | 262.08% |
| Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 263.97B | 276.71B | 308.95B | 359.05B | 403.43B | [{"date":"2022-03-31","value":65.43,"profit":true},{"date":"2023-03-31","value":68.59,"profit":true},{"date":"2024-03-31","value":76.58,"profit":true},{"date":"2025-03-31","value":89,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Cost of Revenue | 251.32B | 264.84B | 296.75B | 346.57B | 388.88B | [{"date":"2022-03-31","value":64.63,"profit":true},{"date":"2023-03-31","value":68.1,"profit":true},{"date":"2024-03-31","value":76.31,"profit":true},{"date":"2025-03-31","value":89.12,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Gross Profit | 12.65B | 11.87B | 12.20B | 12.48B | 14.55B | [{"date":"2022-03-31","value":86.93,"profit":true},{"date":"2023-03-31","value":81.57,"profit":true},{"date":"2024-03-31","value":83.86,"profit":true},{"date":"2025-03-31","value":85.81,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Gross Margin | 4.79% | 4.29% | 3.95% | 3.48% | 3.61% | [{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":89.51,"profit":true},{"date":"2024-03-31","value":82.42,"profit":true},{"date":"2025-03-31","value":72.56,"profit":true},{"date":"2026-03-31","value":75.26,"profit":true}] |
| Operating Expenses | 9.93B | 7.42B | 8.28B | 8.11B | 8.10B | [{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":74.71,"profit":true},{"date":"2024-03-31","value":83.37,"profit":true},{"date":"2025-03-31","value":81.73,"profit":true},{"date":"2026-03-31","value":81.56,"profit":true}] |
| Operating Income | 2.72B | 4.45B | 3.93B | 4.37B | 6.45B | [{"date":"2022-03-31","value":42.19,"profit":true},{"date":"2023-03-31","value":69,"profit":true},{"date":"2024-03-31","value":60.85,"profit":true},{"date":"2025-03-31","value":67.74,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | (973.00M) | (71.00M) | (272.00M) | (105.00M) | (321.00M) | [{"date":"2022-03-31","value":-97300000000,"profit":false},{"date":"2023-03-31","value":-7100000000,"profit":false},{"date":"2024-03-31","value":-27200000000,"profit":false},{"date":"2025-03-31","value":-10500000000,"profit":false},{"date":"2026-03-31","value":-32100000000,"profit":false}] |
| Pre-Tax Income | 1.93B | 4.63B | 3.79B | 4.36B | 6.20B | [{"date":"2022-03-31","value":31.09,"profit":true},{"date":"2023-03-31","value":74.67,"profit":true},{"date":"2024-03-31","value":61.1,"profit":true},{"date":"2025-03-31","value":70.3,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Income Taxes | 636.00M | 905.00M | 629.00M | 878.00M | 1.10B | [{"date":"2022-03-31","value":57.71,"profit":true},{"date":"2023-03-31","value":82.12,"profit":true},{"date":"2024-03-31","value":57.08,"profit":true},{"date":"2025-03-31","value":79.67,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Income After Taxes | 1.29B | 3.73B | 3.16B | 3.48B | 5.10B | [{"date":"2022-03-31","value":25.34,"profit":true},{"date":"2023-03-31","value":73.05,"profit":true},{"date":"2024-03-31","value":61.97,"profit":true},{"date":"2025-03-31","value":68.27,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Income From Continuous Operations | 1.29B | 3.73B | 3.16B | 3.48B | 5.10B | [{"date":"2022-03-31","value":25.34,"profit":true},{"date":"2023-03-31","value":73.05,"profit":true},{"date":"2024-03-31","value":61.97,"profit":true},{"date":"2025-03-31","value":68.27,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Income From Discontinued Operations | (5.00M) | (3.00M) | - | - | - | [{"date":"2022-03-31","value":-500000000,"profit":false},{"date":"2023-03-31","value":-300000000,"profit":false},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true}] |
| Net Income | 1.11B | 3.56B | 3.00B | 3.29B | 4.76B | [{"date":"2022-03-31","value":23.39,"profit":true},{"date":"2023-03-31","value":74.76,"profit":true},{"date":"2024-03-31","value":63.04,"profit":true},{"date":"2025-03-31","value":69.19,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| EPS (Diluted) | 23.69 | 25.98 | 27.42 | 33.10 | 39.15 | [{"date":"2022-03-31","value":60.51,"profit":true},{"date":"2023-03-31","value":66.36,"profit":true},{"date":"2024-03-31","value":70.04,"profit":true},{"date":"2025-03-31","value":84.55,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| MCK | |
|---|---|
| Cash Ratio | 0.06 |
| Current Ratio | 0.85 |
| Quick Ratio | 0.49 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| MCK | |
|---|---|
| ROA (LTM) | 4.99% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| MCK | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 1.01 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.03 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| MCK | |
|---|---|
| Trailing PE | 19.84 |
| Forward PE | 17.54 |
| P/S (TTM) | 0.23 |
| P/B | 4.92 |
| Price/FCF | 28 |
| EV/R | 0.24 |
| EV/Ebitda | 13.64 |
| PEG | 1.52 |
McKesson Corporation (MCK) share price today is $766.5
Yes, Indians can buy shares of McKesson Corporation (MCK) on Vested. To buy
Yes, you can purchase fractional shares of McKesson Corporation (MCK) via the Vested app. You can start investing in McKesson Corporation (MCK) with a minimum investment of $1.
You can invest in shares of McKesson Corporation (MCK) via Vested in three simple steps:
The 52-week high price of McKesson Corporation (MCK) is $999. The 52-week low price of McKesson Corporation (MCK) is $635.12.
The price-to-earnings (P/E) ratio of McKesson Corporation (MCK) is 19.8409
The price-to-book (P/B) ratio of McKesson Corporation (MCK) is 4.92
The dividend yield of McKesson Corporation (MCK) is 0.41%
The market capitalization of McKesson Corporation (MCK) is $90.72B
The stock symbol (or ticker) of McKesson Corporation is MCK
Consider the share price of McKesson Corporation as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether McKesson Corporation has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in McKesson Corporation shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the McKesson Corporation stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of McKesson Corporation and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that McKesson Corporation stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
